These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14682275)

  • 1. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). T-1249 for T-20 salvage.
    Feinberg J
    AIDS Clin Care; 2003 Nov; 15(11):95-6. PubMed ID: 14682275
    [No Abstract]   [Full Text] [Related]  

  • 2. Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. T-20 salvage results hold up at 48 weeks.
    Feinberg J
    AIDS Clin Care; 2003 Sep; 15(9):77-8. PubMed ID: 14666913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). New CCR5 antagonist shows antiretroviral effect.
    Feinberg J
    AIDS Clin Care; 2003 Nov; 15(11):94-5. PubMed ID: 14682273
    [No Abstract]   [Full Text] [Related]  

  • 4. Fuzeon data review.
    GMHC Treat Issues; 2003 Mar; 17(3):6. PubMed ID: 12728857
    [No Abstract]   [Full Text] [Related]  

  • 5. [HIV-1 fusion inhibitor improves treatment in HIV-1-resistant patients].
    Blasko M
    Dtsch Med Wochenschr; 2003 May; 128(19):1032. PubMed ID: 12774800
    [No Abstract]   [Full Text] [Related]  

  • 6. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Single agent therapy for HIV infection?
    Currier J
    AIDS Clin Care; 2003 Nov; 15(11):96. PubMed ID: 14682276
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fusion inhibitors. One year therapy with T-20--initial evaluation].
    Goebel FD
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():42-3. PubMed ID: 15373046
    [No Abstract]   [Full Text] [Related]  

  • 8. New-Fill on "hold" and open-label for T-20.
    Berger DS
    Posit Aware; 2002; 13(1):64-5. PubMed ID: 12216532
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-HIV agents. T-20 (enfurvirtide, Fuzeon).
    TreatmentUpdate; 2005; 17(1):5-6. PubMed ID: 17225316
    [No Abstract]   [Full Text] [Related]  

  • 10. [Strategies for combating resistances in HIV therapy--an exemplifying case].
    Stoehr A
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():70-1. PubMed ID: 15373056
    [No Abstract]   [Full Text] [Related]  

  • 11. T-20 being called "miraculous".
    AIDS Patient Care STDS; 2002 Sep; 16(9):462. PubMed ID: 12412581
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-HIV agents. Introduction to ICAAC: selected highlights from the 43rd annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
    TreatmentUpdate; 2003 Oct; 15(6):1-2. PubMed ID: 17216859
    [No Abstract]   [Full Text] [Related]  

  • 13. T-20 phase III studies underway.
    Giles C
    Surviv News (Atlanta Ga); 2001 Oct; ():1, 12. PubMed ID: 11708190
    [No Abstract]   [Full Text] [Related]  

  • 14. New class of medications approved for advance HIV.
    FDA Consum; 2003; 37(3):5. PubMed ID: 12793380
    [No Abstract]   [Full Text] [Related]  

  • 15. Nailing down another HIV target.
    Richman DD
    Nat Med; 1998 Nov; 4(11):1232-3. PubMed ID: 9809537
    [No Abstract]   [Full Text] [Related]  

  • 16. T-20: entirely new antiretroviral.
    James JS
    AIDS Treat News; 1997 Sep; (No 279):5-6. PubMed ID: 11364691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-20 (Fuzeon) gets priority review.
    AIDS Treat News; 2002 Oct; (384):4-5. PubMed ID: 12434762
    [No Abstract]   [Full Text] [Related]  

  • 18. Fusion inhibitor approved.
    AIDS Patient Care STDS; 2003 May; 17(5):253. PubMed ID: 12816619
    [No Abstract]   [Full Text] [Related]  

  • 19. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Suboptimal response to once-daily abacavir + 3TC + tenofovir.
    Feinberg J
    AIDS Clin Care; 2003 Nov; 15(11):94. PubMed ID: 14682272
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fusion proteins in HIV-AIDS treatment].
    Hennemann A
    Med Monatsschr Pharm; 2003 Sep; 26(9):300-2. PubMed ID: 14526613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.